Related Experiment Video
Updated: Jan 9, 2026
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Artificial intelligence in the detection of multiple sclerosis plaques: Can it influence the treatment decision?
Milica Mastilović1, Verónica Muños-Ramírez2, Andreas M Rauschecker3
1Laboratoire d'imagerie Biomédicale Multimodale (BioMaps), Université Paris-Saclay, CEA, CNRS, Inserm, Service Hopsitalier Frédéric Joliot, Orsay, France; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Background And Purpose:
To monitor multiple sclerosis (MS) progression, follow-up MRIs are used to detect new or enlarging lesions (ELs), typically through manual comparison - a time-consuming, error-prone process. This retrospective study used Pixyl.Neuro.MS®, an AI-based tool, to assess whether AI-assisted readings improve lesion detection and influence treatment decisions.
Materials And Methods:
The study was conducted retrospectively on MS patients. For the comparison of previous and new MRIs, the deep-learning-based software Pixyl.Neuro.MS® was used. This tool performs lesion segmentation and characterization according to their temporal evolution, facilitating the analysis of new lesions and ELs. Subsequently, a new AI-assisted radiological report was generated and compared with the conventional radiological report. By integrating the AI report with neurological assessments, its potential impact on treatment decisions, in contrast to those based solely on the standard radiological report, was evaluated.
Results:
In this cohort of 83 MS patients (mean age 49 years, predominantly female), MRI analysis performed by radiologists with AI assistance significantly outperformed standard radiological interpretation. New lesions were identified in 30.1 % of patients using AI-assisted analysis, compared to 14.6 % with conventional reporting (p < 0.001). ELs were detected in 33.7 % of patients through AI-supported evaluation (p < 0.001), while none were identified with standard interpretation. On average, radiologists, aided by AI, identified more new lesions per patient (0.82 vs. 0.46) and achieved a higher true-positive lesion count. Importantly, integrating AI-assisted findings with clinical data led to treatment modification in 10.8 % of patients, underscoring the potential clinical impact of this approach.
Conclusion:
Artificial intelligence may play a key role in improving detection of new lesions and ELs in patients with MS. The use of Pixyl.Neuro.MS® enhanced radiological interpretation, yielding a more comprehensive assessment of MRI findings compared to conventional analysis. This improved diagnostic precision contributed to revised treatment decisions in a subset of patients.
